Comments for Dr Deanna Attai

Comment on Going Flat After Mastectomy by Dr. Attai’s Flat Closure Research Poster – Not Putting on a Shirt

Dr. Attai’s Flat Closure Research Poster – Not Putting on a Shirt — Sat, 27 Jun 2020 20:19:32 +0000

[…] Dr. Deanna J. Attai ‘s (UCLA) flat closure research results just went live at the virtual poster session from #ASBRS2020! The researchers found that a whopping 30% of patients reported that their surgeon did not support their choice to go flat, and even more patients (36%) reported that flat was not offered to them as an option at all. Close to 3/4 reported being satisfied with their surgical outcome (NPOAS’ own research found a very similar satisfaction rate). Read more about the findings at Dr. Attai’s website. […]

Comment on Going Flat after Mastectomy – Research Survey by Support NPOAS at #ASBrS2020 – Not Putting on a Shirt

Support NPOAS at #ASBrS2020 – Not Putting on a Shirt — Thu, 27 Feb 2020 19:00:41 +0000

[…] We will be engaging providers one on one, providing brochures for surgeons to take back home and use in their practices, learning about and supporting coding and oncoplastic training, and supporting Dr. Deanna Attai (UCLA) as she presents her original flat closure research. […]

Comment on Stage 4 Breast Cancer by Let's Stop Calling Metastatic Breast Cancer "Chronic"! | Nancy's Point

Wed, 19 Feb 2020 17:04:39 +0000

[…] might want to read, Stage 4 Breast Cancer, by Dr. Deanna […]

Comment on Going Flat after Mastectomy – Research Survey by UCLA Researcher Launches Flat Closure Survey – Not Putting on a Shirt

UCLA Researcher Launches Flat Closure Survey – Not Putting on a Shirt — Tue, 29 Oct 2019 21:53:31 +0000

[…] of the American Society of Breast Surgeons and breast cancer researcher at UCLA, has just launched her new study on flat closure! She is making […]

Comment on Metastatic Breast Cancer by October 13th is Metastatic Breast Cancer Awareness Day – Not Putting on a Shirt

Tue, 29 Oct 2019 20:02:28 +0000

[…] more at Dr. Deanna Attai’s blog. and at […]

Comment on Thoughts on Twitter, Community and Loss by How Fabulous is This Group? - Dr Attai

How Fabulous is This Group? - Dr Attai — Tue, 21 May 2019 18:14:48 +0000

[…] Peach died in 2013, I posted some thoughts about how incredible it was that something like Twitter could bring people together in such a […]

Comment on Updated Breast Cancer Genetic Testing Guidelines by Updates from #ASBrS19 - Dr Attai

Updates from #ASBrS19 - Dr Attai — Mon, 06 May 2019 21:02:04 +0000

[…] Dr. David Euhus discussed that genetic testing does not only potentially impact the surgical procedure that is recommended, but may influence the decision for radiation therapy as well as systemic therapy. In addition, results of genetic testing may impact surveillance for additional breast or other cancers in the patient as well as recommendations for family members. The ASBrS recently updated their genetic testing guideline, recommending that genetic testing be considered for newly diagnosed breast cancer patients. (Additional perspective) […]

Comment on Can Breast Cancer Be Treated Without Surgery? by Updates from #ASBrS19 - Dr Attai

Updates from #ASBrS19 - Dr Attai — Mon, 06 May 2019 18:29:51 +0000

[…] Dr. Henry Kuerer presented his research on the percutaneous management of breast cancer in the setting of a pathology complete response (pCR) following neoaduvant (before surgery) chemotherapy. He noted that for survival and recurrence matter most, but side effects and complications are significant concerns for both patients and physicians. I’ve recently covered details of his research on this blog. […]

Comment on Active Surveillance for DCIS by Updates from #ASBrS19 - Dr Attai

Updates from #ASBrS19 - Dr Attai — Mon, 06 May 2019 18:29:23 +0000

[…] The next session was Emerging Strategies in Breast Cancer Care, which focused on “de-escalation” of surgical therapy. Dr. Anna Weis provided an update of clinical trials evaluating active surveillance for low-risk ductal carcinoma in-situ (DCIS): COMET, LORD and LORIS. Approximately 60,000 cases of DCIS are diagnosed annually. Patients undergoing active surveillance do not have surgery, some are treated with endocrine therapy, and all undergo regular monitoring. This is a accepted option in select cases of prostate cancer, and Dr. Weiss noted that there is no difference in overall survival in patients with low-grade DCIS who do not undergo treatment. The LORD and LORIS trials are open in the UK and the COMET study is open in the US. (Additional perspective) […]

Comment on Pinktober by Pinktober | drattai

Pinktober | drattai — Mon, 11 Feb 2019 01:01:25 +0000

[…] This post initially appeared on DrAttai.com […]